GO:0070062; C:extracellular vesicular exosome; IEA:Ensembl
GO:0005887; C:integral component of plasma membrane; IEA:Ensembl
GO:0005743; C:mitochondrial inner membrane; IDA:MGI
GO:0005739; C:mitochondrion; IDA:MGI
GO:0005654; C:nucleoplasm; IEA:Ensembl
GO:0005634; C:nucleus; IDA:MGI
GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:MGI
GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
GO:0071354; P:cellular response to interleukin-6; IEA:Ensembl
GO:0071897; P:DNA biosynthetic process; IMP:MGI
GO:0006260; P:DNA replication; IEA:UniProtKB-KW
GO:0016575; P:histone deacetylation; IEA:Ensembl
GO:0060766; P:negative regulation of androgen receptor signaling pathway; IEA:Ensembl
GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
GO:2000323; P:negative regulation of glucocorticoid receptor signaling pathway; IEA:Ensembl
GO:0010944; P:negative regulation of transcription by competitive promoter binding; IEA:Ensembl
GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
GO:0001649; P:osteoblast differentiation; IEA:Ensembl
GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
GO:0050847; P:progesterone receptor signaling pathway; IEA:Ensembl
GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC